Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait

被引:24
作者
Garewal, G [1 ]
Das, R
Ahluwalia, J
Marwaha, RK
机构
[1] Postgrad Inst Med Educ & Res, Dept Haematol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Paediat, Chandigarh 160012, India
关键词
HFE gene mutations; beta thalassemia trait; iron overload; north India;
D O I
10.1111/j.1600-0609.2004.00390.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine the allele frequency in the north Indian population of the two mutations in the HFE gene, the C282Y and H63D, which are responsible for causing hereditary haemochromatosis particularly in Caucasians of north European descent. We also wanted to correlate these mutations with the iron status in beta thalassemia traits. Patients and Methods: Sixty normal subjects and 215 individuals with beta thalassemia trait from north India were screened for the C282Y and H63D by polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP). We studied the iron status in these subjects and correlated the same with the HFE gene mutations. Results: On screening for the C282Y gene mutation, all individuals were detected to be of the wild-type. The overall allele frequency of H63D was 9.09% with three individuals being homozygous for 63D. No statistically significant difference in the iron status was detected between the individuals of the wild-type and mutant for H63D. Haplotyping of the homozygous 63D alleles revealed the pattern to be identical to the Europeans. Conclusions: Our study shows that H63D is prevalent and C282Y is rare in north Indians and the presence of 63D mutation does not increase body iron as measured by serum ferritin in beta thalassemia traits. Haplotype of H63D gene mutation is of an European haplotype, indicating a common origin.
引用
收藏
页码:333 / 336
页数:4
相关论文
共 15 条
[1]   The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated [J].
Borgna-Pignatti, C ;
Solinas, A ;
Bombieri, C ;
Micciolo, R ;
Gamberini, MR ;
De Stefano, P ;
De Menis, E ;
Pignatti, PF .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (03) :813-816
[2]  
DAWSON DW, 1991, PRACTICAL HAEMATOLOG, P412
[3]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[4]  
Garewal G, 2002, BLOOD, V100, p4B
[5]  
Kaur G, 2003, NATL MED J INDIA, V16, P309
[6]  
Melis MA, 2002, HAEMATOLOGICA, V87, P242
[7]   Geography of HFE C282Y and H63D mutations [J].
Merryweather-Clarke, AT ;
Pointon, JJ ;
Jouanolle, AM ;
Rochette, J ;
Robson, KJH .
GENETIC TESTING, 2000, 4 (02) :183-198
[8]   Global prevalence of putative haemochromatosis mutations [J].
MerryweatherClarke, AT ;
Pointon, JJ ;
Shearman, JD ;
Robson, KJH .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (04) :275-278
[9]  
OLD JM, 1983, THALASSAEMIAS METHOD, P74
[10]   Haemochromatosis in patients with β-thalassaemia trait [J].
Piperno, A ;
Mariani, R ;
Arosio, C ;
Vergani, A ;
Bosio, S ;
Fargion, S ;
Sampietro, M ;
Girelli, D ;
Fraquelli, M ;
Conte, D ;
Fiorelli, G ;
Camaschella, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (03) :908-914